This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Vifor Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of GNHA.Y?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	81,727	0.113%
Institutions	8,510,536	11.7%
Public Companies	63,849,045	88.1%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 111.12% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
98.4%	CSL Limited	63,849,045	US$10.6b	0%	no data
3.85%	Credit Suisse Asset Management (Switzerland)	2,495,385	US$414.6m	0%	0.39%
2.36%	Swisscanto Asset Management AG	1,533,324	US$254.8m	0%	4.83%
2.32%	Vontobel Fonds Services AG	1,502,395	US$249.6m	0%	62.31%
2.25%	Norges Bank Investment Management	1,463,154	US$243.1m	0%	0.03%
0.6%	Sarasin & Partners LLP	390,000	US$64.8m	0%	0.46%
0.32%	The Vanguard Group, Inc.	206,997	US$34.4m	0%	no data
0.14%	BCV Asset Management	89,577	US$14.9m	0%	0.4%
0.13%	Pictet Asset Management Limited	84,006	US$14.0m	0%	0.01%
0.087%	Bellevue Asset Management AG	56,299	US$9.4m	0%	0.1%
0.071%	Bank Von Graffenried AG, Asset Management Arm	45,861	US$7.6m	0%	2.36%
0.068%	1741 Fund Solutions	44,168	US$7.3m	0%	4.32%
0.054%	Legal & General Investment Management Limited	34,991	US$5.8m	-24.8%	no data
0.054%	Amundi Asset Management	34,791	US$5.8m	-94.6%	no data
0.053%	Berner Kantonalbank, Asset Management Arm	34,562	US$5.7m	0%	1.9%
0.052%	Christoph Springer	33,889	US$5.6m	0%	no data
0.046%	Aargauische Kantonalbank, Asset Management Arm	30,060	US$5.0m	0%	0.88%
0.044%	Dimensional Fund Advisors LP	28,828	US$4.8m	-92.9%	no data
0.04%	HSBC Global Asset Management (UK) Limited	25,899	US$4.3m	-2.39%	no data
0.039%	AP Fonden 2	25,073	US$4.2m	0%	0.03%
0.037%	Assenagon Asset Management S.A.	24,214	US$4.0m	0%	0.01%
0.032%	Ignis Investment Services Limited	20,871	US$3.5m	0%	0.01%
0.032%	AP Fonden 4	20,668	US$3.4m	0%	0.02%
0.031%	SPP Fonder AB	20,064	US$3.3m	0%	0.02%
0.021%	BlackRock, Inc.	13,512	US$2.2m	-99.5%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2022/12/26 01:01
End of Day Share Price	2022/12/23 00:00
Earnings	2021/12/31
Annual Earnings	2021/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Vifor Pharma AG is covered by 22 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Armelle Moulin	AlphaValue
Volker Bosse	Baader Helvea Equity Research
Jean-Philippe Bertschy	Bank Vontobel AG